---
schema_version: "secwatch.filing_event.v1"
accession: "0001654954-24-009903"
form_type: "8-K"
ticker: "DRMA"
cik: "0001853816"
company_name: "Dermata Therapeutics, Inc."
filed_at: "2024-08-02T23:59:59+00:00"
generated_at: "2026-05-31T13:30:25.836485+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Dermata Therapeutics ups ATM offering by $505K to $1.66M total

## Summary
- Increased maximum aggregate offering price under ATM agreement with H.C. Wainwright by $505,000 to $1,662,761.
- Previously sold $1,157,247.99 of common stock under the June 7, 2024 Sales Agreement.
- Additional $505,000 of shares authorized under the current prospectus supplement.
- Legal opinion on share legality filed as Exhibit 5.1.

## SEC filing metadata
- accession: 0001654954-24-009903
- form_type: 8-K
- ticker: DRMA
- cik: 0001853816
- company_name: Dermata Therapeutics, Inc.
- filed_at: 2024-08-02T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1853816/000165495424009903/0001654954-24-009903-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1853816/000165495424009903/drma_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001654954-24-009903
- JSON: https://secwatch.observer/filing/0001654954-24-009903.json
- Plain text: https://secwatch.observer/filing/0001654954-24-009903.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.